KYORIN Pharmaceutical Co., Ltd.

¥1,084As of Sun 8 Nov 2026, 12:00 UTC
TSE:4569Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (4.46%)
Div yield 2.31%
ROE 1.57%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.03)
PE TTM 28.67
TSR TTM (20.41%)
Mkt cap ¥62.27B
ROIC 1.06%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥1,213
11.86%
(51.22%)
Hold 8|10|5|10|9
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
22.09
21.88
21.38
20.67
23.37%
10.51%
10.68%
(3.73%)
Revenue¥B
2.982
2.905
3.047
2.991
(2.84%)
(9.54%)
(2.89%)
(1.95%)
Peers (US$395.4M)
Cap (US$)
PE
365.3M
11.06x
294.9M
14.89x
Capital
TTM
5Y
10Y
Leveragex
0.635
0.142
0.145
EBIT/Intx
0.323
0.112
0.111
Own earn%
(9.58)
16.97
16.36
Sh yield%
40.35
15.98
14.74
Owners
Insiders/Inst%
9.03
79.44
Short interest%
1.26
SBC / revenue%
4.09
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
18–22
$1 testx
—
Incr. ROIC%
1